Description
| Product Name | Details | CAT.No | Size |
| Bilirubin, Direct | Suitable for Hitachi 917 | HIT0191A | R1: 6 x 50ml R2: 3 x 22ml |
| Bilirubin, Total | Suitable for Hitachi 917 | HIT0192A | R1: 6 x 50ml R2: 3 x 22ml |
| Bilirubin, Direct | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0191A | R1: 4 x 60ml R2: 2 x 30ml |
| Bilirubin, Total | Suitable for use on Olympus System AU600, AU400, AU640, AU2700 | OLY0192A | R1: 4 x 60ml R2: 2 x 30ml |
| Bilirubin (Direct) | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF191A | R1: 2 x 30ml R2: 8 x 4ml |
| Bilirubin (Total) | Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents | BXCF192A | R1: 2 x 50ml R2: 8 X 4ml |
Product Description
The Biorex Diagnostics Bilirubin Assay is an in vitro diagnostic test designed for the quantitative determination of this key liver-related compound in human serum and plasma. Formed during the breakdown of hemoglobin and processed by the liver for excretion in bile, its measurement provides crucial insights into liver function, hemolytic disorders, and biliary tract health. Monitoring this analyte is particularly important for diagnosing jaundice, evaluating hemolysis, and assessing liver injury, making reliable testing essential for clinical decision-making and patient care.
This assay measures both total and direct forms, offering a complete overview of metabolism and hepatic processing. Abnormal levels can indicate liver dysfunction, bile duct obstruction, hemolytic anemia, or neonatal jaundice. By providing precise and reproducible results, the test supports early detection, treatment planning, and ongoing monitoring of disease progression, which is critical for both adult and neonatal populations.
Key Features
- Quantitative measurement of total and direct forms in serum and plasma
- Supports diagnosis of liver disease, hemolytic anemia, and biliary obstruction
- Spectrophotometric method optimised for automated analyzers (Hitachi, Olympus, Furuno/Daytona)
- Ready-to-use reagents for streamlined laboratory workflow and reduced preparation errors
- Reliable, reproducible, and accurate for routine clinical testing, hospital diagnostics, and research
Benefits
The Biorex Assay delivers clinically meaningful and consistent data, enabling laboratories to detect hepatic dysfunction and hemolytic conditions at an early stage. Its reproducibility ensures reliable results across different laboratory environments, while compatibility with automated analyzers improves efficiency and throughput.
Routine use of this test supports neonatal care, liver disease monitoring, and clinical research. Healthcare professionals can make informed decisions based on accurate measurements, improving patient outcomes and facilitating evidence-based treatment. Its precision, reliability, and versatility make it an essential tool for modern clinical laboratories, neonatal units, and research institutions focused on liver health and hematologic disorders.
Contact Us for more information.